NCT05285527
MiSight 1 Day Safety Post-Approval Study
Active, Not Recruiting
NAAges 8–12InterventionalTreatmentCooperVision, Inc.
~2,400 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:MiSight 1 Day
At a glance
Recruiting sites
0 of 50 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of Microbial Keratitis (MK)
Measured over 3 years
Conditions
Where it's being run
50 sites across 22 statesCalifornia9
Florida6
Texas6
Illinois4
Utah3
Ontario3
Missouri2
North Carolina2
Study leadership
- Kathryn Richdale · STUDY_CHAIR · CooperVision International Limited (CVIL)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Incidence of Microbial Keratitis (MK)3 years
Incidence of Microbial Keratitis (MK) ≥ 1 mm